In addition, studies have found that indobufen can inhibit coagulation function in rats. Compared with aspirin, the duration of antiplatelet efficacy of indobufen was shorter, and the platelet function recovered completely 24 hours after drug withdrawal. However, there are few studies on the antiplatelet efficacy of indobufen. The investigators' previous study found that the inhibitory effect of indobufen 100 mg Bid on COX system in atherosclerosis or healthy volunteers was equivalent to that of aspirin 100 mg QD, but the inhibitory effect on platelet COX-1 channel was significantly weaker than that of aspirin 100 mg QD. In view of this, this study intends to investigate the antiplatelet effect of indobufen 200 mg Bid in patients with coronary atherosclerosis by comparing it with conventional-dose aspirin 100 mg QD.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
100mg aspirin for at least 3 days followed by aspirin 100 mg/d
100mg aspirin for at least 3 days followed by indobufen 200 mg bid
First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
RECRUITINGMPA
Maximum platelet aggregation induced by arachidonic acid
Time frame: Within 24 hours after one month of medication
TXB2
Plasma thromboxaneB2
Time frame: Within 1 month after one month of medication
11-dh-TXB2
Urine 11-dehydro thromboxaneB2
Time frame: Within 1 month after one month of medication
Adverse Events
Monitor the bleeding events of subjects during the trial
Time frame: Within 1 month after the first medication
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.